Funding

MAGIcIAN is funded in the 9^th call (Diagnostics and surveillance of antimicrobial resistance: development of tools, technologies and methods for global use) of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), established by the European Commission. JPIAMR is a global collaborative platform and has engaged 28 nations to curb antibiotic resistance (AMR) with a One Health approach. The initiative coordinates national funding to support transnational research and activities within the six priority areas of the shared JPIAMR Strategic Research and Innovation Agenda – therapeutics, diagnostics, surveillance, transmission, environment and interventions.